Adaptogenics Health Corp.

C$0.29As of Sun 8 Nov 2026, 12:00 UTC
CSE:ADPTConsumer Def
Country Canada
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Packaged Foods
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap C$1.189M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.293
0.94%
(32.41%)
Hold 9|3|11|12|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
6.61%
4.63%
17.24%
16.75%
Revenue$M
0.066
0.069
0.072
0.070
11.92%
11.93%
18.05%
12.13%
Peers (US$0.841M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
7.847
0.609
0.444
EBIT/Intx
1.445
0.227
0.297
Own earn%
(4.32)
(70.49)
(67.43)
Sh yield%
44.73
24.58
22.14
Owners
Insiders/Inst%
1.49
82.10
Short interest%
2.21
SBC / revenue%
2.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
17–24
$1 testx
0.0
Incr. ROIC%
11

Adaptogenics Health Corp., a science led company, focuses on identifying, acquiring, designing, and advancing proprietary peptide and small molecule programs. The company is focusing on evaluating opportunities in metabolic health, muscle preservation, mitochondrial biology and inflammation, including delivery technologies intended to enhance the performance of promising molecules.